Towa Pharmaceutical Co., Ltd. (4553)

Name: Towa Pharmaceutical Co., Ltd. (4553) — histórico de demonstrações financeiras
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

Histórico de receita, lucros e fluxo de caixa das demonstrações financeiras oficiais.

Healthcare · Wall Street (EUA) · Última atualização: 2026-10-02

Towa Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sale ethical drugs in Japan. The company operates through two segments; Domestic and Overseas. It provides its products in the therapeutic areas of digestive system, nervous system, and allergic diseases, as well as vitamins, antibiotics, and oncology products, as well as provide formulations from tablets, capsules, injectable, patches, eye drops, and other products. The company also offers IT service related to healthcare; disease risk testing services; and sale of quasi drugs.

Números-chave

Capitalização de mercado: JPY 172 billion
Receita (exercício encerrado em 2026-03-31): JPY 273.7B
Lucro líquido: JPY 5.2B
Margem bruta: 36.2%
Margem líquida: 1.9%

Ver gráficos interativos e demonstrações completas → Modelo de avaliação (DCF) →

Demonstração de resultados anual

Demonstração de resultados	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Receita total	JPY 273.7B	JPY 259.6B	JPY 227.9B	JPY 208.9B
Lucro bruto	JPY 99.1B	JPY 94.7B	JPY 81.4B	JPY 72.7B
Resultado Operacional (EBIT)	JPY 23.1B	JPY 23.2B	JPY 17.6B	JPY 5.5B
Resultado líquido	JPY 5.2B	JPY 19.0B	JPY 16.2B	JPY 2.2B

Fonte: relatórios públicos da empresa (SEC). Verifique no SEC EDGAR antes de confiar em qualquer número.

Balanços, fluxos de caixa, dados trimestrais e indicadores completos no visualizador interativo de 4553. /companies/us/4553

Empresas semelhantes

4887 · Sawai Group Holdings Co., Ltd.

As informações deste site são apenas educacionais e informativas; não constituem recomendação de investimento. Não publicamos preços-alvo nem recomendações.

English version →Todas as ações

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.